Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The International Institute for the Study, Research, Education and Therapy of Vascular, Heart, Brain and Stroke Disorders is a non-profit research and clinical organization based in Houston, Texas. The institute specializes in the development and evaluation of treatments for cardiovascular and cerebrovascular conditions, with a particular emphasis on acute stroke intervention and secondary prevention. It functions as a coordinating center for large-scale clinical trials, collaborating with major pharmaceutical companies and federal agencies like the National Institutes of Health. Beyond research, the institute provides professional medical education and specialized patient care for complex vascular and heart disorders. It is widely recognized for its contributions to landmark studies such as the Stroke Prevention in Atrial Fibrillation (SPAF) trials. The organization operates within the Texas Medical Center ecosystem, maintaining strong ties with academic and clinical partners.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Institute for study, research, education and therapy of vascular, heart, brain and stroke disorders.